Solid Tumors

Showing NaN - NaN of 63

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)

Recruiting
  • Lung Cancer Squamous Cell
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Solid Tumors, Melanoma, NSCLC Trial in France, Spain, United States (CFT1946, Trametinib)

Recruiting
  • Solid Tumors
  • +4 more
  • Boston, Massachusetts
  • +9 more
Dec 19, 2022

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Solid Tumors Trial in United States (mRNA-4157, Pembrolizumab)

Recruiting
  • Solid Tumors
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +9 more
Sep 20, 2022

Solid Tumors Trial in Worldwide (Cobimetinib)

Completed
  • Solid Tumors
  • Little Rock, Arkansas
  • +16 more
Sep 14, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Orange, California
  • +38 more
Aug 24, 2022

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

Solid Tumors Trial in Worldwide (Pembrolizumab, Standard of Care (SOC))

Recruiting
  • Solid Tumors
  • Tucson, Arizona
  • +374 more
Aug 22, 2022

Solid Tumors Trial in United States (RAIN-32)

Recruiting
  • Solid Tumors
  • Palo Alto, California
  • +9 more
Aug 16, 2022

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Solid Tumors Trial in United States (EZN-2208)

Terminated
  • Solid Tumors
  • Aurora, Colorado
  • +3 more
Jan 29, 2022

Liposarcoma, CRC, Prostate Cancer Trial in United States (PF-07220060, Letrozole, Fulvestrant)

Recruiting
  • Liposarcoma
  • +5 more
  • New Haven, Connecticut
  • +8 more
Jan 20, 2022

Solid Tumors, GI Cancer Trial in Taiwan, United States (CGX1321, Pembrolizumab, encorafenib)

Recruiting
  • Solid Tumors
  • GI Cancer
  • Long Beach, California
  • +25 more
Jan 11, 2022

KRAS Mutant NSCLC, Solid Tumors Trial in Boston (Palbociclib, PD-0325901)

Active, not recruiting
  • KRAS Mutant Non-Small Cell Lung Cancer
  • Solid Tumors
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 18, 2022

Solid Tumors Trial in United States (RMC-4630)

Recruiting
  • Solid Tumors
  • Scottsdale, Arizona
  • +11 more
Jan 6, 2022

Solid Tumors Trial in Worldwide (Tislelizumab, Pamiparib)

Completed
  • Solid Tumors
  • Scottsdale, Arizona
  • +28 more
Oct 27, 2021

Solid Tumors, Lymphoma Trial in Boston, Philadelphia (PM00104)

Terminated
  • Solid Tumors
  • Lymphoma
  • Boston, Massachusetts
  • +1 more
Jul 7, 2021

Advanced Cancer, Solid Tumors Trial in Boston, Nashville (NEV801)

Recruiting
  • Advanced Cancer
  • Solid Tumors
  • Boston, Massachusetts
  • +1 more
Mar 2, 2021

Solid Tumors, Lymphomas Trial in Worldwide (GWN323, PDR001)

Completed
  • Solid Tumors
  • Lymphomas
  • Chicago, Illinois
  • +8 more
Feb 18, 2021

Breast Cancer, Gastric Cancer, Solid Tumors Trial in United States (Pyrotinib)

Unknown status
  • Breast Cancer
  • +3 more
  • Orange, California
  • +9 more
Jan 28, 2021